GlassScriptPhysician profile
Suman Sawhney
NPI 1174520456
$1,803.53
in general payments reported to CMS, 2019-2025
13 companies · $832 in 2025
The $832 reported for 2025 was more than what 82% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2020: $216 · 2022: $109 · 2024: $270 · 2025: $832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,102.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $336.17 | 2020-2025 | Tezspire |
| Boston Scientific Corporation | $266.00 | 2025 | General - Pain Management, Watchman Flx |
| Janssen Pharmaceuticals, INC | $211.71 | 2019-2022 | |
| Stryker Corporation | $202.86 | 2025 | Mako |
| Novo Nordisk INC | $138.65 | 2019 | |
| Seapearl East, INC | $126.27 | 2024 | |
| Coloplast Corp | $118.47 | 2024-2025 | |
| Ironwood Pharmaceuticals, INC | $115.64 | 2019 | |
| Glaxosmithkline, LLC. | $102.87 | 2020 | |
| Corcept Therapeutics | $78.36 | 2025 | Korlym |
| Genzyme Corporation | $67.09 | 2025 | |
| Verastem, INC. | $20.04 | 2020 | |
| Arbor Pharmaceuticals, INC. | $19.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suman Sawhney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.